AMGN · News · 20260916N
Revenue Performance and Mix
AMGEN INC · 2026-09-16 · Importance 53 · Surprise 48 · In source text
Amgen reported a 26% year-over-year increase in Q2 product sales across its six key growth drivers. Total revenue exceeded $10 billion in the quarter. The growth-driver portfolio includes products and pipeline programs such as IMDELLTRA and MariTide, indicating continued emphasis on newer growth assets.
Key facts
- Amgen's total revenues in Q2 exceeded $10 billion. source
- Amgen's six key growth drivers saw a 26% year-over-year increase in Q2 product sales. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | — | Amgen's total revenues in Q2 exceeded $10 billion. |